Results from the Phase 3 SUNRISE clinical trial, published in The Lancet Respiratory Medicine, highlight Tezepelumab as a potential oral corticosteroid-sparing option for patients with severe asthma.

Emerging evidence suggests that some artificial sweeteners may not be as metabolically neutral as once believed.

The REGARDS cohort highlights prior myocardial infarction, even when silent, as a potential driver of accelerated cognitive decline over time.

A large-scale long-term study found that women with PCOS had a 32% higher risk of developing heart disease

A recent study results indicated that having anemia associated with greater levels of developing dementia over time.

In a subgroup analysis of the VESALIUS-CV trial found that Evolocumab reduces the risk of a first major cardiovascular event in high-risk patients with diabetes

A recent study suggests that measures of central obesity, such as waist circumference and waist-to-height ratio, may be more useful than BMI in identifying future heart failure risk.

Emerging evidence suggests menopausal hormone therapy may offer broader health benefits than symptom relief alone.

ACOG release the new, updated clinical guidance on diagnosis of Endometriosis in 2026